More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$4.75B
EPS
0.09
P/E ratio
104
Price to sales
1.75
Dividend yield
--
Beta
1.012659
Previous close
$29.12
Today's open
$29
Day's range
$28.46 - $29.25
52 week range
$14.22 - $30.42
show more
CEO
Paul Keel
Employees
12000
Headquarters
Brea, CA
Exchange
New York Stock Exchange
Shares outstanding
163875397
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Why Envista (NVST) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • 11 hours ago

NVST or ESLOY: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks offers value investors a better bang for their buck right now?
Zacks Investment Research • Feb 18, 2026

Envista Stock Rises Post Q4 Earnings & Revenue Beat, Gross Margin Down
NVST shares jump 22% after Q4 EPS and revenue beat, with profits up 58% and double-digit segment growth despite gross margin pressure.
Zacks Investment Research • Feb 12, 2026

Best Growth Stocks to Buy for February 12th
SANM, NVST and WDC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 12, 2026.
Zacks Investment Research • Feb 12, 2026

3 Stocks With Upgraded Broker Ratings to Buy Amid AI-Related Headwinds
Broker upgrades make J, NVST and TPR top picks amid an AI-driven sell-off as markets demand clearer AI monetization and disciplined spending.
Zacks Investment Research • Feb 11, 2026

Here's Why Envista (NVST) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Feb 10, 2026

Surging Earnings Estimates Signal Upside for Envista (NVST) Stock
Envista (NVST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks Investment Research • Feb 9, 2026

Envista Holdings Corporation (NVST) Hit a 52 Week High, Can the Run Continue?
Envista (NVST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks Investment Research • Feb 9, 2026

Envista (NVST) Upgraded to Strong Buy: What Does It Mean for the Stock?
Envista (NVST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research • Feb 9, 2026

Here's Why Envista (NVST) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Feb 9, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Envista Holdings Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.